Download presentation
Presentation is loading. Please wait.
Published byJohnny Oldroyd Modified over 9 years ago
1
Interpreting Translational Research Findings Incredible Years Conference, Cardiff March 9 th, 2011 Christopher Whitaker, Senior Statistician, NWORTH Tracey Bywater, Research Fellow, School of Psychology
2
Overview Translational research & complex interventions How do we/should we report or interpret results Welsh Sure Start RCT of parent programme & outcome measures Methods of assessing change: – Means & Standard deviations – Effect sizes – Numbers needed to treat Summary & conclusions
3
What is translational research? Translational research transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical applications to tackle all sorts of disorders/diseases etc Translational Research Working Group: www.cancer.gov/researchandfunding/trwg/TRWG-definition-and-TR-continuum
4
Complex interventions EVALUATION – “to strengthen or empower”, more recently it is defined as an assessment of value. Should we look at end outcome only or ‘how we got there’? Social policy interventions, delivered in education, public health practice, or family and children services, are complex interventions (Medical Research Council (MRC), 2009). Complex interventions comprise several interacting components
5
Selected dimensions of complexity according to MRC (2009): implications for development and evaluation Number of components and interactions between them - theoretical understanding is needed of how the intervention causes change, so that weak links in the causal chain can be identified and strengthened Number and difficulty of behaviour changes required by those delivering or receiving the intervention - a thorough process evaluation is needed to identify implementation problems lack of impact may reflect implementation failure rather than genuine ineffectiveness Number and variability of outcomes - a single primary outcome may not be most appropriate, a range of measures may be required
6
Levels of evidence 1. Expert opinion The developer says 2. Case series Observe IY recipients 3. RCT Randomly assign to IY or TAU
7
Randomisation 1:1 ratio
8
Welsh Sure Start Study Hutchings et al (2007) Parenting intervention in Sure Start services for children at risk of developing conduct disorder: pragmatic randomised controlled trial Children aged 3-4 years, randomised 2:1 Targeted population – over cut off on Eyberg Child Behaviour Inventory – Intensity 7-point scale, 36-252, cut off 127 – Problem scale – yes/no answers, 0-36, cut off 11
9
Measures Measures were administered at baseline, 6, 12, and 18 months post baseline. They included (amongst others): Kendall Self Control Rating Scale (Kendall & Wilcox, 1979) Conners Hyperactivity Questionnaire (Conners, 1994) Strengths & Difficulties Questionnaire (Goodman, 1997)
10
ECBI-IFollow up TAU144.0 (n = 49) IY122.3 (n = 104) ECBI mean at 6-month (1 st ) follow up
11
ECBI-IBaselineFollow up TAU141.3144.0 (n = 49) IY146.8122.3 (n = 104) ECBI mean at 6-month (1 st ) follow up and baseline
12
IY mean = 122.3, TAU mean = 144.0
13
ECBI-IBaselineFollow up TAU141.3144.0 (n = 49)(26.8)(33.0) IY146.8122.3 (n = 104)(27.0)(35.1) ECBI mean and SD at 6-month (1 st ) follow up and baseline
14
IY mean = 122.3, TAU mean = 144.0
15
ECBI-IBaselineFollow upBL - FU TAU141.3144.0+2.7 (n = 49)(26.8)(33.0) IY146.8122.3-24.5 (n = 104)(27.0)(35.1) -27.2 ECBI mean and SD at 6-month (1 st ) follow up, baseline and change
16
Conclusion – IY lowers ECBI by 27.2 points on the scale NO – 27.2 is an approximate value Statistical analysis - gives a more precise value Take account of each participants 1.Baseline value 2.Sure start area Statistical analysis finds IY lowers ECBI by 25.05 points on the scale
17
Better summary IY lowers ECBI by 25.05 points on the scale 95% Confidence Interval (CI) for this mean is 14.92 to 35.18 Based on this sample of data we are 95% confident that the effect of IY is to reduce ECBI between 14.92 and 35.18 points on the scale
18
95% CI for other measures meanLo CIHi CISignificance ECBI-I25.0514.9235.18p <.001 ECBI-P4.422.006.85p <.001 Conners3.391.475.31p <.001 Kendall SRCS8.160.6815.61p =.033 SDQ total1.52-0.243.28p =.091
19
Normal distribution plots of data
20
Normal distribution plots of artificial data (SD = 5)
21
Conclusion from the plots Differences in the means are the same SD is different Lots of overlap suggests lesser effect Can we measure overlap Difference in means relative to SD
22
Effect size Uses the mean difference Uses the variability of the mean difference (SD) Is comparable between the measures How to calculate effect size – different ways, we use Cohen’s d: d = (IY mean – TAU mean) / SD
23
Which measure has IY had biggest effect on Effect sizeLo CIHi CISignificant ECBI-I0.890.541.24p <.001 ECBI-P0.630.280.98p <.001 Conners0.610.270.96p <.001 Kendall SCRS0.380.030.73p =.033 SDQ total0.30-0.050.65p =.091
24
At baseline all children have ECBI-I >= 127 OR ECBI-P >= 11 At (1 st ) Follow up NumberBelow both cut-offs Benefit (%) TAU49918% IY1043837%
25
Idea behind Number Needed to Treat With IY 37% benefit, with TAU 18% benefit In 6 families with IY approximately 2 benefit In 6 families with TAU approximately 1 benefits So in 6 families 1 more benefits with IY than with TAU
26
Number Needed to Treat (NNT) Calculation 38/104 benefit with IY 9/49 benefit with TAU Difference is 38/104 – 9/49 = 0.1817 NNT = 1 / 0.1817 = 5.5 NNT is the number of families that need to be treated with IY rather than TAU for one additional family to benefit
27
Attributable Risk Reduction (%) 10 20 30 40 0 -10 2.5 3.3 5 10 NNT NNT 5.5 (72.5, 3.1) NUMBER NEEDED to TREAT Benefit
28
Summary & Conclusions Be clear on – What research question is being asked – What service managers/policy makers want to know and why Ensure sensitive validated measures are used Identify most useful method of presenting data for target audience, e.g. in this case – Mean values are sensitive to change but not easy to interpret, SD & other factors should be taken in to account – Effect sizes are derived from means and shows magnitude of change – NNT is not very sensitive but useful to give guidance on numbers required to reduce prevalence rates & therefore costs
29
References Conners, C. K. (1994). The Conners Rating Scales: Use in clinical assessment, treatment planning and research. In M. Maruish (Ed.), Use of Psychological Testing for Treatment Planning and Outcome Assessment. Hillsdale, New Jersey: Erlbaum. Eyberg, S. M. (1980). Eyberg Child Behavior Inventory. Journal of Clinical Child Psychology, 9, 27. Goodman, R. (1997). The Strengths and Difficulties Questionnaire: A research note. Journal of Child Psychology, Psychiatry, and Allied Disciplines, 38 (5), 581-586. Hutchings, J., Bywater, T., Daley, D., Gardner, F., Whitaker, C., Jones, K., Eames, C. & Edwards, R. T. (2007) Parenting intervention in Sure Start services for children at risk of developing conduct disorder: pragmatic randomised controlled trial. British Medical Journal, 334, 678- 682. Accessible at: http://www.bmj.com/content/334/7595/678.fullhttp://www.bmj.com/content/334/7595/678.full Kendall, P. & Wilcox, L. (1979). Self-control in children: Development of a rating scale. Journal of Consulting and Clinical Psychology, 47, 1020-1029. Medical Research Council (2009). Developing and Evaluating Complex Interventions: New guidance. Accessible at: www.mrc.ac.uk/complexinterventionsguidancewww.mrc.ac.uk/complexinterventionsguidance
30
Additional reading Effect sizes – Cohen, J. (1988). Statistical Power for the Behavioural Sciences. Erlbaum, Hillsdale, NJ, USA. Calculating the Number Needed to Treat (Altman & Anderson, 1999) Accessible at: – http://www.bmj.com/content/319/7223/1492.full http://www.bmj.com/content/319/7223/1492.full Confidence Intervals for the difference between 2 proportions: – http://faculty.vassar.edu/lowry/prop2_ind.html http://faculty.vassar.edu/lowry/prop2_ind.html
31
Diolch yn Fawr Questions??????? c.j.whitaker@bangor.ac.ukc.j.whitaker@bangor.ac.uk 01248 383218 t.bywater@bangor.ac.ukt.bywater@bangor.ac.uk 01248 383845
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.